Johnson & Johnson to split into two companies

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business.

The company selling prescription drugs and medical devices will keep Johnson & Johnson as its name, the company said Friday. The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnson's, and Band-Aid. A name was not disclosed for the new company.

Details are sparse, but the company expect the split to occur in the next two years.

"We believe that the new Johnson & Johnson and the new consumer health company would each be able to more effectively allocate resources to deliver for patients and consumers, drive growth and unlock significant value," J&J CEO Alex Gorsky said in a statement. 

CDC panel approves Moderna and J&J boosters

Gorsky will hand over the reins as chief executive to Joaquin Duato, currently vice chairman of the company's executive committee, on January 3, 2022, J&J said. The split is expected to be completed by fall of 2023.

The company was formed by brothers Robert Wood Johnson, Edward Mead Johnson and James Wood Johnson in 1886 as a maker of surgical supplies. 

The announcement comes just days after General Electric said that it plans to split into three separate companies.

Shares of Johnson & Johnson rose 3% before the market opened.

f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.